Fierce Pharma Asia—China deals safe from COINS?; Key WCLC data; Legend’s new CEO

Most drug licensing deals with China will be safe from rules being drafted by the U.S. Treasury Department, Reuters reports. Akeso and Summit's ivonescimab, B7-H3 ADCs and a surprise negative overall survival trend from Enhertu headlined WCLC26. Plus more.